Does the media refer more to ESTA or MMED?

In the previous week, MiniMed Group had 11 more articles in the media than Establishment Labs. MarketBeat recorded 13 mentions for MiniMed Group and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.61 beat MiniMed Group's score of 0.52 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ESTA or TFX?

In the previous week, Teleflex had 12 more articles in the media than Establishment Labs. MarketBeat recorded 14 mentions for Teleflex and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.61 beat Teleflex's score of 0.43 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teleflex 2 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to ESTA or HAE?

In the previous week, Establishment Labs had 1 more articles in the media than Haemonetics. MarketBeat recorded 2 mentions for Establishment Labs and 1 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.34 beat Establishment Labs' score of 0.61 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ESTA or LIVN?

In the previous week, LivaNova had 2 more articles in the media than Establishment Labs. MarketBeat recorded 4 mentions for LivaNova and 2 mentions for Establishment Labs. LivaNova's average media sentiment score of 0.78 beat Establishment Labs' score of 0.61 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, ITGR or ESTA?

Integer has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $3.66 34.52 Establishment Labs $211.08M 9.06 -$51.06M -$1.31 N/A

Is ITGR or ESTA more profitable?

Integer has a net margin of 6.97% compared to Establishment Labs' net margin of -15.82%. Integer's return on equity of 12.79% beat Establishment Labs' return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Establishment Labs -15.82% -196.69% -10.73%

Does the media prefer ITGR or ESTA?

In the previous week, Integer had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Integer and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.61 beat Integer's score of 0.48 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Establishment Labs (ESTA) Competitors

$64.17 +0.47 (+0.74%)

Closing price 04:00 PM Eastern

Extended Trading

$64.18 +0.02 (+0.02%)

As of 07:30 PM Eastern

Compare

ESTA vs. MMED, TFX, HAE, LIVN, and ITGR

Should you buy Establishment Labs stock or one of its competitors? Establishment Labs's main competitors and comparable companies include MiniMed Group (MMED), Teleflex (TFX), Haemonetics (HAE), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Establishment Labs compare to MiniMed Group?

Establishment Labs (NASDAQ:ESTA) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, analyst recommendations, profitability and dividends.

Establishment Labs has higher earnings, but lower revenue than MiniMed Group. Establishment Labs is trading at a lower price-to-earnings ratio than MiniMed Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.06	-$51.06M	-$1.31	N/A
MiniMed Group	$3.10B	1.77	-$333M	-$0.68	N/A

Establishment Labs presently has a consensus target price of $100.25, suggesting a potential upside of 56.23%. MiniMed Group has a consensus target price of $24.14, suggesting a potential upside of 24.00%. Given Establishment Labs' stronger consensus rating and higher probable upside, equities research analysts clearly believe Establishment Labs is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 0.0% of MiniMed Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, MiniMed Group had 11 more articles in the media than Establishment Labs. MarketBeat recorded 13 mentions for MiniMed Group and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.61 beat MiniMed Group's score of 0.52 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	3 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MiniMed Group has a net margin of 0.00% compared to Establishment Labs' net margin of -15.82%. MiniMed Group's return on equity of 0.00% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
MiniMed Group	N/A	N/A	N/A

Summary

MiniMed Group beats Establishment Labs on 8 of the 15 factors compared between the two stocks.

How does Establishment Labs compare to Teleflex?

Establishment Labs (NASDAQ:ESTA) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Establishment Labs has higher earnings, but lower revenue than Teleflex. Establishment Labs is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.06	-$51.06M	-$1.31	N/A
Teleflex	$1.99B	2.66	-$905.64M	-$23.29	N/A

In the previous week, Teleflex had 12 more articles in the media than Establishment Labs. MarketBeat recorded 14 mentions for Teleflex and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.61 beat Teleflex's score of 0.43 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	2 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Establishment Labs has a net margin of -15.82% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
Teleflex	-39.67%	11.93%	5.44%

Establishment Labs presently has a consensus price target of $100.25, suggesting a potential upside of 56.23%. Teleflex has a consensus price target of $155.20, suggesting a potential upside of 24.21%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
Teleflex	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.67

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Establishment Labs has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

Summary

Establishment Labs beats Teleflex on 10 of the 17 factors compared between the two stocks.

How does Establishment Labs compare to Haemonetics?

Establishment Labs (NASDAQ:ESTA) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

Establishment Labs presently has a consensus target price of $100.25, suggesting a potential upside of 56.23%. Haemonetics has a consensus target price of $99.78, suggesting a potential downside of 5.50%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Establishment Labs had 1 more articles in the media than Haemonetics. MarketBeat recorded 2 mentions for Establishment Labs and 1 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.34 beat Establishment Labs' score of 0.61 indicating that Haemonetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Haemonetics has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.06	-$51.06M	-$1.31	N/A
Haemonetics	$1.33B	3.60	$97.31M	$2.04	51.75

Haemonetics has a net margin of 7.12% compared to Establishment Labs' net margin of -15.82%. Haemonetics' return on equity of 27.55% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
Haemonetics	7.12%	27.55%	9.65%

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 2.1% of Haemonetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Establishment Labs has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market.

Summary

Haemonetics beats Establishment Labs on 10 of the 17 factors compared between the two stocks.

How does Establishment Labs compare to LivaNova?

Establishment Labs (NASDAQ:ESTA) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

In the previous week, LivaNova had 2 more articles in the media than Establishment Labs. MarketBeat recorded 4 mentions for LivaNova and 2 mentions for Establishment Labs. LivaNova's average media sentiment score of 0.78 beat Establishment Labs' score of 0.61 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LivaNova	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a net margin of 12.82% compared to Establishment Labs' net margin of -15.82%. LivaNova's return on equity of 16.35% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
LivaNova	12.82%	16.35%	7.76%

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Establishment Labs has higher earnings, but lower revenue than LivaNova. Establishment Labs is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.06	-$51.06M	-$1.31	N/A
LivaNova	$1.39B	3.04	-$242.47M	$3.38	22.63

Establishment Labs has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Establishment Labs currently has a consensus price target of $100.25, suggesting a potential upside of 56.23%. LivaNova has a consensus price target of $84.13, suggesting a potential upside of 9.97%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities analysts clearly believe Establishment Labs is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55

Summary

LivaNova beats Establishment Labs on 9 of the 16 factors compared between the two stocks.

How does Establishment Labs compare to Integer?

Integer (NYSE:ITGR) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Integer has a net margin of 6.97% compared to Establishment Labs' net margin of -15.82%. Integer's return on equity of 12.79% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Establishment Labs	-15.82%	-196.69%	-10.73%

Integer currently has a consensus target price of $109.86, suggesting a potential downside of 13.06%. Establishment Labs has a consensus target price of $100.25, suggesting a potential upside of 56.23%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

Integer has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.52
Establishment Labs	$211.08M	9.06	-$51.06M	-$1.31	N/A

99.3% of Integer shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integer has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

In the previous week, Integer had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Integer and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.61 beat Integer's score of 0.48 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Integer beats Establishment Labs on 9 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ESTA vs. The Competition

Export

Metric	Establishment Labs	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.90B	$5.51B	$7.30B	$13.05B
Dividend Yield	N/A	1.79%	2.52%	14.40%
P/E Ratio	-48.98	24.95	273.68	25.69
Price / Sales	9.06	68.84	613.85	92.66
Price / Cash	N/A	32.86	79.75	52.21
Price / Book	79.22	5.68	10.34	6.29
Net Income	-$51.06M	$149.51M	$3.50B	$360.55M
7 Day Performance	-5.30%	-2.33%	-1.70%	-1.85%
1 Month Performance	-9.16%	-5.95%	-4.61%	-4.37%
1 Year Performance	56.55%	4.94%	12.41%	3.56%

Establishment Labs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ESTA Establishment Labs	2.7534 of 5 stars	$64.17 +0.7%	$100.25 +56.2%	+54.0%	$1.90B	$211.08M	N/A	1,004
MMED MiniMed Group	2.6299 of 5 stars	$21.21 +0.4%	$23.77 +12.0%	N/A	$5.96B	$3.10B	N/A	2,800	Short Interest Increase
TFX Teleflex	4.4866 of 5 stars	$125.64 +0.7%	$152.90 +21.7%	+4.4%	$5.31B	$1.99B	N/A	15,500	Positive News Analyst Upgrade
HAE Haemonetics	1.8075 of 5 stars	$108.98 +0.2%	$99.78 -8.4%	+119.7%	$4.96B	$1.33B	53.44	3,009
LIVN LivaNova	2.8375 of 5 stars	$78.73 +0.7%	$84.13 +6.9%	+47.1%	$4.34B	$1.39B	23.28	3,300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ESTA) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Competitors

ESTA vs. MMED, TFX, HAE, LIVN, and ITGR

How does Establishment Labs compare to MiniMed Group?

Summary

How does Establishment Labs compare to Teleflex?

Summary

How does Establishment Labs compare to Haemonetics?

Summary

How does Establishment Labs compare to LivaNova?

Summary

How does Establishment Labs compare to Integer?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Competitors

ESTA vs. MMED, TFX, HAE, LIVN, and ITGR

How does Establishment Labs compare to MiniMed Group?

Which has stronger valuation and earnings, ESTA or MMED?

Do analysts rate ESTA or MMED?

Do insiders and institutionals believe in ESTA or MMED?

Does the media refer more to ESTA or MMED?

Is ESTA or MMED more profitable?

Summary

How does Establishment Labs compare to Teleflex?

Which has higher valuation & earnings, ESTA or TFX?

Does the media prefer ESTA or TFX?

Is ESTA or TFX more profitable?

Do analysts prefer ESTA or TFX?

Do institutionals and insiders hold more shares of ESTA or TFX?

Which has more risk and volatility, ESTA or TFX?

Summary

How does Establishment Labs compare to Haemonetics?

Do analysts rate ESTA or HAE?

Does the media refer more to ESTA or HAE?

Which has higher earnings & valuation, ESTA or HAE?

Is ESTA or HAE more profitable?

Do insiders and institutionals have more ownership in ESTA or HAE?

Which has more volatility & risk, ESTA or HAE?

Summary

How does Establishment Labs compare to LivaNova?

Does the media refer more to ESTA or LIVN?

Is ESTA or LIVN more profitable?

Do insiders & institutionals have more ownership in ESTA or LIVN?

Which has preferable valuation & earnings, ESTA or LIVN?

Which has more risk and volatility, ESTA or LIVN?

Do analysts recommend ESTA or LIVN?

Summary

How does Establishment Labs compare to Integer?

Is ITGR or ESTA more profitable?

Do analysts prefer ITGR or ESTA?

Which has better valuation & earnings, ITGR or ESTA?

Do institutionals and insiders hold more shares of ITGR or ESTA?

Which has more risk and volatility, ITGR or ESTA?

Does the media prefer ITGR or ESTA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools